Lexicon Pharmaceuticals Inc (LXRX)
1.13
-0.08
(-6.22%)
USD |
NASDAQ |
Nov 05, 11:41
Lexicon Pharmaceuticals Price: 1.13 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 1.22 | 1.23 | 1.20 | 1.205 | 3.202M |
| Nov 01, 2024 | 1.195 | 1.38 | 1.16 | 1.22 | 21.00M |
| Oct 31, 2024 | 1.95 | 1.95 | 1.95 | 1.95 | 0.000 |
| Oct 30, 2024 | 2.01 | 2.08 | 1.92 | 1.95 | 6.462M |
| Oct 29, 2024 | 1.86 | 2.075 | 1.84 | 2.03 | 4.124M |
| Oct 28, 2024 | 1.82 | 1.945 | 1.805 | 1.86 | 3.049M |
| Oct 25, 2024 | 1.86 | 1.88 | 1.78 | 1.80 | 3.163M |
| Oct 24, 2024 | 1.88 | 1.92 | 1.83 | 1.84 | 2.103M |
| Oct 23, 2024 | 1.96 | 2.025 | 1.831 | 1.86 | 3.214M |
| Oct 22, 2024 | 1.97 | 1.985 | 1.86 | 1.94 | 2.880M |
| Oct 21, 2024 | 2.07 | 2.075 | 1.94 | 1.95 | 3.107M |
| Oct 18, 2024 | 2.02 | 2.175 | 2.02 | 2.08 | 4.868M |
| Oct 17, 2024 | 1.93 | 2.12 | 1.91 | 2.01 | 4.649M |
| Oct 16, 2024 | 1.80 | 1.97 | 1.79 | 1.91 | 3.190M |
| Oct 15, 2024 | 1.77 | 1.80 | 1.73 | 1.79 | 1.811M |
| Oct 14, 2024 | 1.74 | 1.84 | 1.725 | 1.79 | 2.466M |
| Oct 11, 2024 | 1.69 | 1.74 | 1.67 | 1.74 | 2.251M |
| Oct 10, 2024 | 1.61 | 1.70 | 1.60 | 1.69 | 1.910M |
| Oct 09, 2024 | 1.68 | 1.69 | 1.61 | 1.63 | 1.653M |
| Oct 08, 2024 | 1.65 | 1.71 | 1.64 | 1.68 | 1.404M |
| Oct 07, 2024 | 1.66 | 1.71 | 1.65 | 1.68 | 1.480M |
| Oct 04, 2024 | 1.63 | 1.71 | 1.62 | 1.69 | 2.963M |
| Oct 03, 2024 | 1.60 | 1.63 | 1.57 | 1.61 | 1.465M |
| Oct 02, 2024 | 1.55 | 1.655 | 1.55 | 1.61 | 3.721M |
| Oct 01, 2024 | 1.58 | 1.59 | 1.51 | 1.58 | 2.662M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.00
Minimum
Oct 09 2023
9.09
Maximum
Feb 02 2021
2.779
Average
2.23
Median
Apr 20 2022
Price Benchmarks
| Viatris Inc | 11.50 |
| AIM ImmunoTech Inc | 0.2474 |
| Perspective Therapeutics Inc | 12.20 |
| Protalix BioTherapeutics Inc | 1.29 |
| Armata Pharmaceuticals Inc | 2.22 |
Price Related Metrics
| PS Ratio | 81.18 |
| PEG Ratio | -0.0986 |
| Price to Book Value | 1.702 |
| Earnings Yield | -69.03% |
| Market Cap | 408.49M |
| PEGY Ratio | -0.0986 |